Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00688662 · ClinicalTrials.gov registry record · NA

Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction

A NA study of Sphincter of Oddi Dysfunction, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
214
Enrollment target
7
Study locations

NCT00688662 is a NA study of Sphincter of Oddi Dysfunction that has completed, run by Medical University of South Carolina. The registered enrollment target is 214 participants. The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00688662, a NA study of Sphincter of Oddi Dysfunction, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
214 participants
Enrollment target
7
Study locations

Study Summary

The Evaluating Predictors \& Interventions in Sphincter of Oddi Dysfunction(SOD) study (EPISOD) is a randomized sham-controlled study of biliary and pancreatic sphincterotomy as treatment for patients with pain after cholecystectomy fitting the criteria for sphincter of Oddi dysfunction type III.

Interventions

  • PROCEDURE ERCP with sphincterotomy
  • PROCEDURE ERCP without sphincterotomy

Study Locations (7)

Connecticut

  • Yale University - New Haven

Indiana

  • Indiana University - Indianapolis

Minnesota

  • University of Minnesota - Minneapolis

Missouri

  • Midwest Therapeutic Endoscopy Consultants - St Louis

South Carolina

  • Medical University of South Carolina Digestive Disease Center - Charleston

Texas

  • Methodist Dallas Medical Center - Dallas

Washington

  • Virginia Mason Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 214 participants
Start Date 2008-07
Est. Completion 2016-12
Phase NA

What the Registry Record Tells You About NCT00688662

The ClinicalTrials.gov registry entry for NCT00688662 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sphincter of Oddi Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which ERCP with sphincterotomy is the first listed.

NCT00688662 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Connecticut, Indiana, Minnesota.

Frequently Asked Questions

What is clinical trial NCT00688662 about?

NCT00688662 is a clinical study titled "Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction". The Evaluating Predictors \& Interventions in Sphincter of Oddi Dysfunction(SOD) study (EPISOD) is a randomized sham-controlled study of biliary and pancreatic sphincterotomy as treatment for patients with pain after cholecystectomy fitting the criteria for sphincter of Oddi dysfunction type III.

What is the current status of trial NCT00688662?

This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2008-07. Estimated completion is 2016-12.

What conditions does trial NCT00688662 study?

This clinical trial studies the following conditions: Sphincter of Oddi Dysfunction.

What interventions are being tested in trial NCT00688662?

The interventions under investigation include: ERCP with sphincterotomy (PROCEDURE), ERCP without sphincterotomy (PROCEDURE).

Who is sponsoring clinical trial NCT00688662?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00688662 being conducted?

This trial has 7 study locations across Connecticut, Indiana, Minnesota, Missouri, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.